Lifeboat Foundation

Marine biologists are racing against the clock to decode the bizarre aquatic behavior.

Google CEO Sundar Pichai has admitted that the generative AI boom caught Google by surprise.

During an event at Stanford University earlier this month, the tech boss said his company was “surprised” by the sudden public interest in AI.

Continue reading “Sundar Pichai admits the generative AI boom took Google by surprise” »

It watches, saps the very spirit. And the worst thing of all is I watch it. I can’t not look. It’s like a drug, a horrible drug. You can’t resist it. It’s an addiction. These words of testimony are babbled by the crumbling Colonel Grover to describe O.B.I.T. — The Outer Band Individuated Teletracer — a hellishly precise surveillance machine of questionable origin. Uncovered by a murder investigation at a Defense Department research center, O.B.I.T. proves to be an insidious instrument that breeds fear and hostility. Both cautionary tale and tight courtroom drama, this haunting episode explores the fear and hostility that result when all privacy is eliminated…and all secrets are revealed! Alan Baxter, Jeff Corey and Peter Breck star!

Bacterium could head off food versus fuel dilemma by producing chemicals from agricultural waste.

Apple presents OpenELM An Efficient Language Model Family with Open-source Training and Inference Framework.

Apple presents OpenELM

An Efficient Language Model Family with Open-source Training and Inference Framework.

Continue reading “Paper page — OpenELM: An Efficient Language Model Family with Open-source Training and Inference Framework” »

That led the Microsoft Research machine learning expert to wonder how much an AI model could learn using only words a 4-year-old could understand – and ultimately to an innovative training approach that’s produced a new class of more capable small language models that promises to make AI more accessible to more people.

Large language models (LLMs) have created exciting new opportunities to be more productive and creative using AI. But their size means they can require significant computing resources to operate.

While those models will still be the gold standard for solving many types of complex tasks, Microsoft has been developing a series of small language models (SLMs) that offer many of the same capabilities found in LLMs but are smaller in size and are trained on smaller amounts of data.

Using electromagnetic fields or implanted medical devices to stimulate the brain can have benefits, but also carries risks. Computer simulations that reflect the unique complexity of each patient can help predict and solve problems before they arise.

Regenerating damaged tissues or organs has been a dream of scientists for decades. Now, researchers at the FMI and Novartis Biomedical Research have discovered a new molecule that activates a protein involved in regeneration. The tool holds promise for advancing our understanding of how organisms repair damaged tissue.

People with advanced neuroendocrine tumors in the digestive system may benefit from a treatment combination that includes the drug Lu 177-dotatate (Lutathera), according to the results of a first-of-its-kind clinical trial.

All participants in the trial, called NETTER-2, had advanced neuroendocrine tumors in the gastrointestinal tract or pancreas that had not yet been treated.

Those who received Lu 177-dotatate plus octreotide (Sandostatin) lived almost three times as long without their cancer getting worse (progression-free survival) as those who received octreotide alone—a median of nearly 23 months, versus 8.5 months. And the number of people whose tumors shrank, sometimes completely, was nearly five times greater in those who received both drugs compared to those who only received octreotide.